MedPath

Mucuna pruriens in Parkinson disease: an international clinical trial

Not Applicable
Conditions
Parkinsons Disease
Registration Number
PACTR201611001882367
Lead Sponsor
Fondazione Grigioni per il Morbo di Parkinson
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
70
Inclusion Criteria

(a) diagnosis of idiopathic PD according to UK Brain Bank criteria (Hughes et al., 1992);
(b) newly diagnosed PD within the past 2 years;
(c) never treated with levodopa or treated for ¿6 months during the disease course but levodopa discontinued since at least 3 months; (d) age ¿30 years.

Exclusion Criteria

(i) signs of cognitive impairment (according to DSM-IV-TR criteria or MMSE<26) limiting the availability for a written informed consent;
(ii) clinically significant psychiatric illness (e.g. severe depression or psychosis);
(iii) Hoehn and Yahr stage 5/5;
(iv) severe, unstable medical conditions (e.g. neoplasms; unstable diabetes mellitus; heart, renal or liver failure);
(v) pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Summary index of the 39-item Parkinson¿s Disease Questionnaire (PDQ-39) quality-of-life scale (Jankinson et al., 1997)
Secondary Outcome Measures
NameTimeMethod
(b) number of patients withdrawn from the study or lost to follow up;(a) the patient-rated functional status on the mobility subscale of the PDQ-39 and other domains such as compliance;(c) dyskinesias, measured with items 32 to 35 of the UPDRS part IV;(d) levodopa-induced motor response fluctuations throughout the course of the study measured with items 36 to 39 of the UPDRS part IV;(e) any adverse events defined as the frequency, severity, nature, and duration of any adverse event throughout the course of the study;(f) working status and absence from paid and (g) resource utilisation outside of the participating hospitals work, measured with a standardised questionnaires (Verschuur et al., 2015)
© Copyright 2025. All Rights Reserved by MedPath